Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zabrina L Brumme

Showing results (21-30 of 210) with videos related to

Pageof 21
Sort By:
ACS Medicinal Chemistry Letters|November 19, 2021
2-Trifluoromethylthiazole-5-carboxamides: Analogues of a Stilbene-Based Anti-HIV Agent that Impact HIV mRNA ProcessingMaryam Zamiri, Peter K Cheung, Mark A Brockman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2025
Investigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical SamplesHanwei Sudderuddin, Zhong Dang, Birgit Watson, et al.
Evolution, Medicine, and Public Health|November 10, 2021
Concordance of HIV transmission risk factors elucidated using viral diversification rate and phylogenetic clusteringAngela McLaughlin, Paul Sereda, Chanson J Brumme, et al.
Antiviral Therapy|November 30, 2005
Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimenZabrina L Brumme, Bethany M Henrick, Chanson J Brumme, et al.
Journal of Immunological Methods|May 16, 2012
HLA class I sequence-based typing using DNA recovered from frozen plasmaLaura A Cotton, Manal Abdur Rahman, Carmond Ng, et al.
Virology|February 20, 2019
Modulation of TCR-dependent NFAT signaling is impaired in HIV-1 Nef isolates from elite controllersSteven W Jin, Tristan J Markle, Gursev Anmole, et al.
Viruses|June 30, 2018
Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural ProductsKhumoekae Richard, David E Williams, E Dilip de Silva, et al.
Journal of Virology|June 7, 2002
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistanceP Richard Harrigan, Mahboob Salim, David K Stammers, et al.
Journal of Clinical Microbiology|November 19, 2010
In vitro selection of clinically relevant bevirimat resistance mutations revealed by "deep" sequencing of serially passaged, quasispecies-containing recombinant HIV-1David J H F Knapp, P Richard Harrigan, Art F Y Poon, et al.
Biochemical and Biophysical Research Communications|April 17, 2012
Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein VpuZafrul Hasan, Jonathan M Carlson, Hiroyuki Gatanaga, et al.
Pageof 21

Showing results (21-30 of 210) with videos related to

Sort By:
Pageof 21
ACS Medicinal Chemistry Letters|November 19, 2021
2-Trifluoromethylthiazole-5-carboxamides: Analogues of a Stilbene-Based Anti-HIV Agent that Impact HIV mRNA ProcessingMaryam Zamiri, Peter K Cheung, Mark A Brockman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 13, 2025
Investigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical SamplesHanwei Sudderuddin, Zhong Dang, Birgit Watson, et al.
Evolution, Medicine, and Public Health|November 10, 2021
Concordance of HIV transmission risk factors elucidated using viral diversification rate and phylogenetic clusteringAngela McLaughlin, Paul Sereda, Chanson J Brumme, et al.
Antiviral Therapy|November 30, 2005
Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimenZabrina L Brumme, Bethany M Henrick, Chanson J Brumme, et al.
Journal of Immunological Methods|May 16, 2012
HLA class I sequence-based typing using DNA recovered from frozen plasmaLaura A Cotton, Manal Abdur Rahman, Carmond Ng, et al.
Virology|February 20, 2019
Modulation of TCR-dependent NFAT signaling is impaired in HIV-1 Nef isolates from elite controllersSteven W Jin, Tristan J Markle, Gursev Anmole, et al.
Viruses|June 30, 2018
Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural ProductsKhumoekae Richard, David E Williams, E Dilip de Silva, et al.
Journal of Virology|June 7, 2002
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistanceP Richard Harrigan, Mahboob Salim, David K Stammers, et al.
Journal of Clinical Microbiology|November 19, 2010
In vitro selection of clinically relevant bevirimat resistance mutations revealed by "deep" sequencing of serially passaged, quasispecies-containing recombinant HIV-1David J H F Knapp, P Richard Harrigan, Art F Y Poon, et al.
Biochemical and Biophysical Research Communications|April 17, 2012
Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein VpuZafrul Hasan, Jonathan M Carlson, Hiroyuki Gatanaga, et al.
Pageof 21